Clinical Trial Update: A Trial of Baricitinib in Patients With Cardiac Sarcoidosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating baricitinib in patients with cardiac sarcoidosis has been announced. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Sarcoidosis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Stanford University | Conditions: Cardiac Sarcoidosis | Phase 2 | Status: NOT_YET_RECRUITING